Scoreboard / HCA
HCA Healthcare, Inc. HCA
Issue No. 12 pick · September 11, 2026 · Updated October 16, 2026
Setup Snapshot
The Setup in One Card
How HCA moved and the catalyst behind the move, from its Issue No. 12 write-up. It is not on the current Scoreboard, so it carries no Friday Five Score this week.
Issue No. 12
Original Pick
Sector Trend
Leadingup 5.4 percent
Covered In
Issue No. 12 · September 11, 2026
Catalyst
Demand ConfirmationTold a conference that 99 percent of the business performed as expected or better and the core business runs at the high side of its 4 to 6 percent EBITDA growth range
Return measured from the Thursday, September 3 close to the Thursday, September 10 close, the week it appeared in Issue No. 12.
Why It Moved
The Story Behind the Move
Catalyst
Told a conference that 99 percent of the business performed as expected or better and the core business runs at the high side of its 4 to 6 percent EBITDA growth range
Why It Mattered
Health Care was the worst sector of the week at negative 4.39 percent and HCA rose 2.93 percent inside it, on no new product, no raised forecast and no deal. It is also the most liquid pick in the issue at roughly 574 million dollars a day and the furthest below its own peak at 75.7 percent of a 52 week high.
Risk Note
A 2.93 percent move on conference remarks is the weakest catalyst in this issue, and the company filed nothing with the regulator between September 1 and September 10. The policy drag is real and self disclosed: roughly 22,000 adjusted admissions moved from exchange coverage to uninsured as enhanced premium tax credits expired, and the company cut its own 2026 outlook during the year from an original 29.10 to 31.50 dollars a share.
Reader Takeaway
A company confirming nothing broke is not a company reporting improvement. In a week when everything else was repriced, that distinction was worth seven points of relative performance, and it is still a confirmation rather than a catalyst.
Continue the Research
Put HCA Back in Context
The stock page is one piece of the weekly research. Continue with the original issue, the full public ranking, or the method behind the analysis.
This page is for educational and informational purposes only. It is not financial advice, investment advice, or a recommendation to buy or sell any security.